COVID-19
Regístrese
Enfermedades Infecciosas y Microbiología Clínica
Suscribe to the journal
Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica Generalized use of Nirmatrelvir plus ritonavir (Paxlovid): Raising concerns
Journal Information
Back to article

Statistics

Follow this link to access the full text of the article

Scientific letter
Generalized use of Nirmatrelvir plus ritonavir (Paxlovid): Raising concerns
Uso generalizado de Nirmatrelvir más ritonavir (Paxlovid): Algunos planteamientos
David Sánchez Fabraa,
Corresponding author
davidsanchezfabra@gmail.com

Corresponding author.
, Tina Herrero Jordánb
a F.E.A (Facultativo Especialistas de Área) de Medicina Interna, Servicio de Medicina Interna del Hospital Reina Sofía de Tudela, Tudela, Navarra, Spain
b F.E.A (Facultativo Especialista de Área) de Neumología, Servicio de Medicina Interna del Hospital Reina Sofía de Tudela, Tudela, Navarra, Spain
Read
532
Times
was read the article
84
Total PDF
448
Total HTML
Share statistics
Article information
ISSN: 0213005X
Original language: English
DOI:10.1016/j.eimc.2022.04.007
The statistics are updated each day
Year/Month Html Pdf Total
2024 April 28 7 35
2024 March 31 10 41
2024 February 40 6 46
2024 January 49 1 50
2023 December 28 2 30
2023 November 40 2 42
2023 October 58 8 66
2023 September 39 1 40
2023 August 16 0 16
2023 July 4 0 4
2023 June 5 3 8
2023 May 6 2 8
2023 April 4 0 4
2023 March 14 6 20
2023 February 86 34 120
2022 June 0 2 2
Show all

Follow this link to access the full text of the article

Subscribe to our newsletter

Publish in
Enfermedades Infecciosas y Microbiología Clínica
Special content about COVID-19
Free access articles
Executive summary of the consensus document on the shared...
Enferm Infecc Microbiol Clin. 2024;42:102-7
Executive Summary of the Consensus Statement of the Spanish...
Enferm Infecc Microbiol Clin. 2020;38:283-8
SARS-CoV-2 infection as trigger multisystem inflammatory...
Enferm Infecc Microbiol Clin. 2021;39:262-4


La Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica agradece la colaboración de:

SOCIOS PROTECTORES

    - Pfizer GEP, S.L.U.
    - Shionogi, S.L.U.
    - AbbVie Spain, S.L.U.
    - Gilead Sciences, S.L.U.
    - Vircell Spain, S.L.U.
    - Roche Diagnostics, S.L.U.
    - ASTRAZENECA FARMACÉUTICA SPAIN, S.A.
    - Qiagen Iberia S.L.
    - Laboratorios ViiV Healthcare, S.L.

SOCIOS PATROCINADORES

- Becton Dickinson S.A.U.
- Janssen-Cilag, S.A.
- Angelini Farmacéutica, S.A.
- Biomerieux España, S,A.U.
- Merck Sharp & Dohme de España, S.A.
- Hologic Iberia, S.L.U.
- Laboratorios Menarini S.A.
- Accelerate Diagnostics S.L.
- Abbott Laboratories, S.A.
- Cepheid Iberia S.L.U.
- Illumina Productos de España. S.L.U.
- DiaSorin Iberia, S.A.
- GlaxoSmithKline, S.A.
- Sysmex España S.L.

Enfermedades Infecciosas y Microbiología Clínica follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos